Foundry Partners’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $483K | Buy |
16,170
+8
| +0% | +$239 | 0.03% | 234 |
|
|
2024
Q4 | $463K | Buy |
16,162
+381
| +2% | +$10.9K | 0.02% | 242 |
|
|
2024
Q3 | $610K | Buy |
15,781
+509
| +3% | +$19.7K | 0.03% | 236 |
|
|
2024
Q2 | $492K | Buy |
+15,272
| New | +$492K | 0.03% | 246 |
|
|
2023
Q3 | – | Sell |
-160,588
| Closed | -$3.45M | – | 299 |
|
|
2023
Q2 | $3.45M | Buy |
160,588
+24,108
| +18% | +$518K | 0.21% | 138 |
|
|
2023
Q1 | $3.27M | Buy |
+136,480
| New | +$3.27M | 0.21% | 152 |
|
|
2021
Q4 | – | Sell |
-46,230
| Closed | -$913K | – | 354 |
|
|
2021
Q3 | $913K | Sell |
46,230
-197,216
| -81% | -$3.89M | 0.03% | 264 |
|
|
2021
Q2 | $5.76M | Sell |
243,446
-2,259
| -0.9% | -$53.4K | 0.2% | 157 |
|
|
2021
Q1 | $5.82M | Buy |
+245,705
| New | +$5.82M | 0.19% | 161 |
|